More than half of the family and friends making decisions for critically ill patients have significantly different estimates for the patient's survival than their doctor--but that's not only because of a misunderstanding, University of Pittsburgh School of Medicine researchers report in today's issue of the Journal of the American Medical Association.
The majority of those differences also were due to the decision maker holding fundamentally different and overly optimistic beliefs about the patient's prognosis. The research team anticipates that this finding will help in training physicians to better communicate with the family and friends of patients so they can make the best decisions for their loved one.
"It isn't a bad thing for a patient's family and friends to have hope that they will recover," said lead author Douglas B. White, M.D., M.A.S., professor in the Pitt School of Medicine's Department of Critical Care Medicine, and director of the department's Program on Ethics and Decision Making. "However, it is problematic when those overly optimistic expectations result in more invasive treatments in dying patients and delayed integration of palliative care that can alleviate suffering."
Between 2005 and 2009, Dr. White and his colleagues surveyed 229 people who had agreed to be the "surrogate decision maker" for hospitalized patients in four intensive care units at the University of California, San Francisco Medical Center, where Dr. White previously was a faculty member. These surrogates were typically family members or friends of the patient. They also surveyed the physicians caring for the patients for which the surrogates were making decisions.
The researchers asked both the surrogates and the doctors to estimate the chances that the patient would survive hospitalization on a scale of 0 (no chance of survival) to 100 (definite survival). They did not know each other's answers.
In 53 percent of cases, the answers differed by more than 20 percent. The surrogates were usually more optimistic than the doctors, however the doctors' estimates of the patient prognosis were ultimately far more accurate.
The researchers then asked the surrogates to guess what they thought the patient's doctor answered. Generally, the surrogates would guess somewhere in between their estimate and the doctor's real estimate. That revealed that the surrogates understood they were being more optimistic than what the doctor had been communicating to them.
The surrogates explained this in many ways, the most common being that they believed if they maintained hope, then the patient would do better than expected, or that they knew the patient better than the doctor and believed the patient had strengths the doctor didn't know about. They also often had an optimism grounded in religious beliefs.
"As doctors, we want to provide the best possible care for our patients. In critically ill patients, that means we must do a better job communicating with the people who are making decisions for our patients," said Dr. White, who also holds the UPMC Endowed Chair for Ethics in Critical Care Medicine. "Given the results of this study, we're working to develop and test interventions both to improve the comprehensibility of the prognosis doctors give to surrogates, and to better attend to the emotional and psychological factors that may influence the surrogate's expectations for their loved one's outcome."
Additional researchers on this study are Natalie Ernecoff, M.P.H., Praewpannarai Buddadhumaruk, R.N., M.S., and Seoyeon Hong, Ph.D., all of Pitt; Lisa Weissfeld, Ph.D., of Statistics Collaborative in Washington D.C.; J. Randall Curtis, M.D., M.P.H., of the University of Washington; and John M. Luce, M.D., and Bernard Lo, M.D., both of the University of California, San Francisco.
This research was supported by National Institutes of Health grants KL2 RR024130 and R01 HL094553; and by the Greenwall Foundation.
About the University of Pittsburgh School of Medicine
As one of the nation's leading academic centers for biomedical research, the University of Pittsburgh School of Medicine integrates advanced technology with basic science across a broad range of disciplines in a continuous quest to harness the power of new knowledge and improve the human condition. Driven mainly by the School of Medicine and its affiliates, Pitt has ranked among the top 10 recipients of funding from the National Institutes of Health since 1998. In rankings recently released by the National Science Foundation, Pitt ranked fifth among all American universities in total federal science and engineering research and development support.
Likewise, the School of Medicine is equally committed to advancing the quality and strength of its medical and graduate education programs, for which it is recognized as an innovative leader, and to training highly skilled, compassionate clinicians and creative scientists well-equipped to engage in world-class research. The School of Medicine is the academic partner of UPMC, which has collaborated with the University to raise the standard of medical excellence in Pittsburgh and to position health care as a driving force behind the region's economy. For more information about the School of Medicine, see http://www.medschool.pitt.edu.